Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test

[1]  H. Obata,et al.  The nociceptive mechanism of 5‐hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats , 2009, European journal of pain.

[2]  V. Granados-Soto,et al.  Acid increases inflammatory pain in rats: effect of local peripheral ASICs inhibitors. , 2009, European journal of pharmacology.

[3]  Daniel Hoyer,et al.  Molecular biology of 5-HT receptors , 2008, Behavioural Brain Research.

[4]  X. Codony,et al.  Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. , 2008, Pharmacology & therapeutics.

[5]  D. Finn,et al.  The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. , 2007, European journal of pharmacology.

[6]  Jisheng Han,et al.  Roles of 5-Hydroxytryptamine (5-HT) Receptor Subtypes in the Inhibitory Effects of 5-HT on C-Fiber Responses of Spinal Wide Dynamic Range Neurons in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  C. Regan,et al.  SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. , 2006, European journal of pharmacology.

[8]  H. Greiner,et al.  2‐Alkyl‐3‐(1,2,3,6‐tetrahydropyridin‐4‐yl)‐1H‐indoles as Novel 5‐HT6 Receptor Agonists. , 2005 .

[9]  J. Neumaier,et al.  5-HT6 receptors: a novel target for cognitive enhancement. , 2005, Pharmacology & therapeutics.

[10]  V. Granados-Soto,et al.  Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test , 2005, Pain.

[11]  Ya-Yun Wang,et al.  Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain , 2005, Neuroscience Letters.

[12]  A. Cowan,et al.  Standardization of the rat paw formalin test for the evaluation of analgesics , 2005, Psychopharmacology.

[13]  J. Choi,et al.  Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. , 2004, European journal of pharmacology.

[14]  S. Kumabe,et al.  Blockade of peripheral 5HT3 receptor attenuates the formalin-induced nocifensive behavior in persistent temporomandibular joint inflammation of rat , 2004, Neuroscience Letters.

[15]  K. Krobert,et al.  Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i) , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  C. Marsden,et al.  5-ht6 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[17]  E. Senba,et al.  5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats , 2002, PAIN.

[18]  Paul J. Harrison,et al.  5‐HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [125I]SB‐258585 , 2002, Synapse.

[19]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[20]  J. Lopez-Garcia,et al.  5‐HT1B but not 5‐HT6 or 5‐HT7 receptors mediate depression of spinal nociceptive reflexes in vitro , 2002, British journal of pharmacology.

[21]  A. Basbaum,et al.  The 5-HT3 Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors , 2002, The Journal of Neuroscience.

[22]  Keiji Ishizaki,et al.  Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. , 2001, European journal of pharmacology.

[23]  F. Cunha,et al.  The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception , 2001, Neuroscience.

[24]  K. Schauenstein,et al.  mRNA Expression of Serotonin Receptors in Cells of the Immune Tissues of the Rat , 2000, Brain, Behavior, and Immunity.

[25]  D. Middlemiss,et al.  Characterization of [125I]‐SB‐258585 binding to human recombinant and native 5‐HT6 receptors in rat, pig and human brain tissue , 2000 .

[26]  A. Eschalier,et al.  Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats , 2000, Pain.

[27]  D. Middlemiss,et al.  Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue. , 2000, British journal of pharmacology.

[28]  S. Tsai,et al.  Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease , 1999, Neuroscience Letters.

[29]  A. Sleight,et al.  Investigation of stretching behaviour induced by the selective 5‐HT6 receptor antagonist, Ro 04–6790, in rats , 1999, British journal of pharmacology.

[30]  M. Millan,et al.  The induction of pain: an integrative review , 1999, Progress in Neurobiology.

[31]  A. Tokunaga,et al.  5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery , 1998, Pain.

[32]  E. F. Espejo,et al.  Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors , 1998, Brain Research.

[33]  D. Jourdan,et al.  Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats , 1997, Brain Research.

[34]  J. Sawynok,et al.  Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes , 1997, Neuroscience.

[35]  G. Wilkin,et al.  Identification of 5‐hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes , 1997, British journal of pharmacology.

[36]  M. Martres,et al.  Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats , 1996, Synapse.

[37]  J. Levine,et al.  Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Blier,et al.  Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators , 1996, Neuropharmacology.

[39]  J. Stamford.  Descending control of pain. , 1995, British journal of anaesthesia.

[40]  F. Monsma,et al.  Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. , 1995, The Journal of pharmacology and experimental therapeutics.

[41]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[42]  I. Martin,et al.  Molecular biology of 5-HT receptors , 1994, Neuropharmacology.

[43]  J. Schwartz,et al.  A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. , 1993, Biochemical and biophysical research communications.

[44]  D. Sibley,et al.  Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. , 1993, Molecular pharmacology.

[45]  A. Malmberg,et al.  Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. , 1992, The Journal of pharmacology and experimental therapeutics.

[46]  E. Anderson,et al.  Serotonin preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activating 5-HT1A receptors , 1992, Brain Research.

[47]  P. Heller,et al.  Mediation of serotonin hyperalgesia by the cAMP second messenger system , 1992, Neuroscience.

[48]  J. Levine,et al.  Serotonin is a directly-acting hyperalgesic agent in the rat , 1992, Neuroscience.

[49]  J. Giordano,et al.  Receptor mediation of 5-HT-induced inflammation and nociception in rats , 1992, Pharmacology Biochemistry and Behavior.

[50]  T. Crisp,et al.  Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. , 1991, General pharmacology.

[51]  W. Soudijn,et al.  The concept of selectivity in 5-HT receptor research. , 1990, European journal of pharmacology.

[52]  G. Gebhart,et al.  Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[53]  S. Ireland,et al.  Pharmacological characterization of 5‐hydroxytryptamine‐induced hyperpolarization of the rat superior cervical ganglion , 1987, British journal of pharmacology.

[54]  E. Anderson,et al.  Serotonin depolarizes type A and C primary afferents: an intracellular study in bullfrog dorsal root ganglion , 1985, Brain Research.

[55]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[56]  T. Yaksh,et al.  Spinal serotonin terminal system mediates antinociception. , 1979, The Journal of pharmacology and experimental therapeutics.

[57]  D. Dubuisson,et al.  The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats , 1977, Pain.

[58]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.

[59]  &NA; &NA;.  Bradykinin and serotonin effects on various types of cutaneous nerve fibres P. W. Beck and H. O. Handwerke, Pflügers Arch. ges. Physiol., 347 (1974) 209–222 , 1975, PAIN.